Overview
Status
Active
Registry date
2019-08-22
Share capital
10 000,00 PLN
Registered address
ul. Jasna 12, 38-500 Trepcza, Poland
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 84 days for 2021).
- 202517/08/2026
- 202408/07/2025
- 202319/07/2024
- 202228/06/2023
- 202107/10/2022
- 202010/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 50.42kMedianUSD 55.35kAverageUSD 2.71m
Net profit
This companyUSD -34.98kMedianUSD -1.27kAverageUSD -92.09k
Operating costs
This companyUSD 85.02kMedianUSD 66.19kAverageUSD 2.67m
Assets
This companyUSD 60.38kMedianUSD 133.95kAverageUSD 3.03m
Industry
Authorized Representatives
Lucjan Adam Witkowski – President of the Management Board
Manner of representation
Each member of the management board independently or a commercial proxy is authorized to submit declarations of will on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Lucjan Adam Witkowskiage 49 | 9 | $2,431.12 | 90% |
Marek Antoni Witkowskiage 76 | 1 | $270.12 | 10% |
Lucjan Adam Witkowski and Marek Antoni Witkowski hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2019-10-03.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 29, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Jun 2, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Starosta Powiatu Sanok |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2022-02-01 | Development of an innovative product: a sterile swab for collecting samples from the upper respiratory tract of horses. | $75,278$75,278 | Operational Programme Smart Growth |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| Pominnosp. z o.o. | $65,991.17 | pominno.pl | ||
| Luna Laboratorysp. z o.o. | $61,894.23 | lunalab.pl | ||
| GenomtecS.A. | $54,746.36 | genomtec.com | ||
| Przedsiębiorstwo Wielobranżowe Genezasp. z o.o. | $54,163.54 | geneza.eu | ||
| Receptonsp. z o.o. | $50,611.05 | receptonbiotech.com | ||
| Biostat Research And Developmentsp. z o.o. | $50,225.77 | biostat.com.pl | ||
| Zawamedsp. z o.o. | $43,909.06 | zawamed.pl | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| Immbionicsp. z o.o. | $31,756.23 | immbionic.com.pl |
FAQ
The main business activity of SAN River focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on August 22, 2019.
The headquarters is located at: ul. Jasna 12, 38-500 Trepcza.
The share capital of the company is PLN 10,000 (approx. $2,701).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $76,087 in 2024, which is a decrease of 49.3% compared to 2023.
No, in 2024 the company was not profitable, reporting a net loss of $24,005.
The largest operating cost category falls under employee remuneration. This category amounted to $33,723 in 2024, representing 34% of all operating expenses.
Last updated: 2026-08-17
